CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Orient Pharma Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Orient Pharma Co Ltd
9F, No.368, Section 1
Fu-Hsing South Road, Da'an District
Phone: +886 223257621p:+886 223257621 TAIPEI, 112  Taiwan Ticker: 41664166
Business Summary
Orient Pharma Co., Ltd. is a Taiwan-based company principally engaged in the research, development, manufacture and sales of western medicines. The Company's main products include hyperlipidemic drugs, diabetes drugs, cardiovascular drugs and drugs for musculoskeletal diseases. The Company is also involved in the original equipment manufacturer (OEM) manufacturing business and clinical trial business. The Company distributes its products in domestic market and to overseas markets, such as the United States, Ireland and mainland China.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board Jing HongTsai 2/1/2018 11/24/2008
General Manager ChuntongHuang 2/21/2023 2/21/2023
Deputy General Manager-Global Business Division YujianXiao 8/8/2011 8/8/2011
6 additional Officers and Directors records available in full report.

General Information
Number of Employees: 173 (As of 9/30/2016)
Outstanding Shares: 223,035,000 (As of 12/31/2023)
Shareholders: 1,684
Stock Exchange: TPO
Fax Number: +886 227550656


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, April 28, 2024